|
1
|
Mashima T and Tsuruo T: Defects of the
apoptotic pathway as therapeutic target against cancer. Drug Resist
Updat. 8:339–343. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Indran IR, Tufo G, Pervaiz S and Brenner
C: Recent advances in apoptosis, mitochondria and drug resistance
in cancer cells. Biochim Biophys Acta. 1807:735–745. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Elmore S: Apoptosis: a review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cotter TG: Apoptosis and cancer: the
genesis of a research field. Nat Rev Cancer. 9:501–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu Q: Restoring p53-mediated apoptosis in
cancer cells: new opportunities for cancer therapy. Drug Resist
Updat. 9:19–25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kastan MB: Wild-type p53: tumors can’t
stand it. Cell. 128:837–840. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Graaf AO, de Witte T and Jansen JH:
Inhibitor of apoptosis proteins: new therapeutic targets in
hematological cancer? Leukemia. 18:1751–1759. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park WR and Nakamura Y: p53CSV, a novel
p53-inducible gene involved in the p53-dependent cell-survival
pathway. Cancer Res. 65:1197–1206. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tamura Y, Iijima M and Sesaki H: Mdm35p
imports Ups proteins into the mitochondrial intermembrane space by
functional complex formation. EMBO J. 29:2875–2887. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niu P, Liu L, Gong Z, Tan H, Wang F, Yuan
J, Feng Y, Wei Q, Tanguay RM and Wu T: Overexpressed heat shock
protein 70 protects cells against DNA damage caused by ultraviolet
C in a dose-dependent manner. Cell Stress Chaperones. 11:162–169.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Salvesen GS and Duckett CS: IAP proteins:
blocking the road to death’s door. Nat Rev Mol Cell Biol.
3:401–410. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Felix RS, Colleoni GW, Caballero OL,
Yamamoto M, Almeida MS, Andrade VC, Chauffaille MdeL, Silva WA Jr,
Begnami MD, Soares FA, et al: SAGE analysis highlights the
importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma
tumorigenesis. Cancer Lett. 278:41–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neve RM, Chin K, Fridlyand J, Yeh J,
Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al: A
collection of breast cancer cell lines for the study of
functionally distinct cancer subtypes. Cancer Cell. 10:515–527.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ali S and Coombes RC: Endocrine-responsive
breast cancer and strategies for combating resistance. Nat Rev
Cancer. 2:101–112. 2002. View
Article : Google Scholar
|
|
15
|
Eccles SA, Aboagye EO, Ali S, Anderson AS,
Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant
HE, et al: Critical research gaps and translational priorities for
the successful prevention and treatment of breast cancer. Breast
Cancer Res. 15:R922013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Raguz S, Adams C, Masrour N, Rasul S,
Papoutsoglou P, Hu Y, Cazzanelli G, zhou Y, Patel N, Coombes C, et
al: Loss of O’-methylguanine-DNA methyltransferase confers
collateral sensitivity to carmustine in topoisomerase II-mediated
doxorubicin resistant triple negative breast cancer cells. Biochem
Pharmacol. 85:186–196. 2013. View Article : Google Scholar
|
|
17
|
Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu
LH, Ng TT, Karadedou CT, Millour J, Ip YC, Cheung YN, et al:
Constitutively nuclear FOXO3a localization predicts poor survival
and promotes Akt phosphorylation in breast cancer. PLoS One.
5:e122932010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tolhurst RS, Thomas RS, Kyle FJ, Patel H,
Periyasamy M, Photiou A, Thiruchelvam PT, Lai CF, Al-Sabbagh M,
Fisher RA, et al: Transient over-expression of estrogen receptor-α
in breast cancer cells promotes cell survival and
estrogen-independent growth. Breast Cancer Res Treat. 128:357–368.
2011. View Article : Google Scholar
|
|
19
|
Rasul S, Balasubramanian R, Filipović A,
Slade MJ, Yagüe E and Coombes RC: Inhibition of gamma-secretase
induces G2/M arrest and triggers apoptosis in breast cancer cells.
Br J Cancer. 100:1879–1888. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yagüe E, Arance A, Kubitza L, O’Hare M,
Jat P, Ogilvie CM, Hart IR, Higgins CF and Raguz S: Ability to
acquire drug resistance arises early during the tumorigenesis
process. Cancer Res. 67:1130–1137. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Filipović A, Gronau JH, Green AR, Wang J,
Vallath S, Shao D, Rasul S, Ellis IO, Yagüe E, Sturge J, et al:
Biological and clinical implications of nicastrin expression in
invasive breast cancer. Breast Cancer Res Treat. 125:43–53. 2011.
View Article : Google Scholar
|
|
22
|
Vichai V and Kirtikara K: Sulforhodamine B
colorimetric assay for cytotoxicity screening. Nat Protoc.
1:1112–1116. 2006. View Article : Google Scholar
|
|
23
|
Yague E, Armesilla AL, Harrison G, Elliott
J, Sardini A, Higgins CF and Raguz S: P-glycoprotein (MDR1)
expression in leukemic cells is regulated at two distinct steps,
mRNA stabilization and translational initiation. J Biol Chem.
278:10344–10352. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Raguz S, De Bella MT, Slade MJ, Higgins
CF, Coombes RC and Yagüe E: Expression of RPIP9 (Rap2 interacting
protein 9) is activated in breast carcinoma and correlates with a
poor prognosis. Int J Cancer. 117:934–941. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Almeida B, Silva A, Mesquita A,
Sampaio-Marques B, Rodrigues F and Ludovico P: Drug-induced
apoptosis in yeast. Biochim Biophys Acta. 1783:1436–1448. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun JM, Spencer VA, Li L, Yu Chen H, Yu J
and Davie JR: Estrogen regulation of trefoil factor 1 expression by
estrogen receptor alpha and Sp proteins. Exp Cell Res. 302:96–107.
2005. View Article : Google Scholar
|
|
27
|
Nachmias B, Ashhab Y and Ben-Yehuda D: The
inhibitor of apoptosis protein family (IAPs): an emerging
therapeutic target in cancer. Semin Cancer Biol. 14:231–243. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang S, Bai L, Lu J, Liu L, Yang CY and
Sun H: Targeting inhibitors of apoptosis proteins (IAPs) for new
breast cancer therapeutics. J Mammary Gland Biol Neoplasia.
17:217–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Garber ME, Troyanskaya OG, Schluens K,
Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen
GD, Perou CM, Whyte RI, et al: Diversity of gene expression in
adenocarcinoma of the lung. Proc Natl Acad Sci USA. 98:13784–13789.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu KH, Patterson AP, Wang L, Marquez RT,
Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I,
et al: Selection of potential markers for epithelial ovarian cancer
with gene expression arrays and recursive descent partition
analysis. Clin Cancer Res. 10:3291–3300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Skrzypczak M, Goryca K, Rubel T, Paziewska
A, Mikula M, Jarosz D, Pachlewski J, Oledzki J and Ostrowski J:
Modeling oncogenic signaling in colon tumors by multidirectional
analyses of microarray data directed for maximization of analytical
reliability. PLoS One. 5:e130912010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Molinari AM, Bontempo P, Schiavone EM,
Tortora V, Verdicchio MA, Napolitano M, Nola E, Moncharmont B,
Medici N, Nigro V, et al: Estradiol induces functional inactivation
of p53 by intracellular redistribution. Cancer Res. 60:2594–2597.
2000.PubMed/NCBI
|
|
34
|
Fernández-Cuesta L, Anaganti S, Hainaut P
and Olivier M: Estrogen levels act as a rheostat on p53 levels and
modulate p53-dependent responses in breast cancer cell lines.
Breast Cancer Res Treat. 125:35–42. 2011. View Article : Google Scholar
|
|
35
|
Somaï S, Chaouat M, Jacob D, Perrot JY,
Rostène W, Forgez P and Gompel A: Antiestrogens are pro-apoptotic
in normal human breast epithelial cells. Int J Cancer. 105:607–612.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang GJ, Kimijima I, Onda M, Kanno M,
Sato H, Watanabe T, Tsuchiya A, Abe R and Takenoshita S:
Tamoxifen-induced apoptosis in breast cancer cells relates to
down-regulation of bcl-2, but not bax and bcl-X(L), without
alteration of p53 protein levels. Clin Cancer Res. 5:2971–2977.
1999.PubMed/NCBI
|
|
37
|
Potting C, Tatsuta T, König T, Haag M, Wai
T, Aaltonen MJ and Langer T: TRIAP1/PRELI complexes prevent
apoptosis by mediating intramitochondrial transport of phosphatidic
acid. Cell Metab. 18:287–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cain K: Chemical-induced apoptosis:
formation of the Apaf-1 apoptosome. Drug Metab Rev. 35:337–363.
2003. View Article : Google Scholar
|
